NanoBio Corporation

Realizing the promise of intranasal vaccines.

NanoBio Corporation changed its corporate name to BlueWillow Biologics in 2018; the company was originally founded to develop topical nanoscale therapies for dermatology applications and later evolved into a vaccines-focused biopharmaceutical company using its intranasal NanoVax technology platform.

Partnerships

 

  

  

 

  

  

 

  

  

Clients